FindTrial
Sign In

The Changes of Plasma Cytokines in Different Glucose Tolerence Population and its Relationship with the First Phase of Insulin Secretion

The Changes of Plasma Cytokines in Different Glucose Tolerence Population and its Relationship with the First Phase of Insulin Secretion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-15006928
Enrollment
Unknown
Registered
2015-08-16
Start date
2015-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

NGT :NA
IGT:NA
DM:NA

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 75g oral glucose tolerance test (OGTT) was performed in all subjects, and the diagnoses of T2DM were based on the diagnostic criteria of World Health Organization (WHO) in 1999.

Exclusion criteria

Exclusion criteria: 1. Acute and chronic complications of diabetes; 2. Hepatic or renal disease, and systemic corticosteroid treatment; 3. stage 2 hypertension (resting blood pressure>=160/100 mmHg), history of cardiovascular disease (myocardial infarction, unstable angina, stroke, peripheral artery disease, or cardiovascular revascularization); 4. Women who were currently pregnant and breastfeeding were also excluded from this study.

Design outcomes

Primary

MeasureTime frame
Plasma cytokines;Plasma glucose;serum insulin;HbA1c;—

Secondary

MeasureTime frame
lipids;—

Countries

China

Contacts

Public ContactHuacong Deng
huacong_deng@163.com+86 13618325491

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026